VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial.

Guénaëlle Levallet,Fatéméh Dubois,Nicolas Elie,Christian Creveuil,Solenn Brosseau,Claire Danel,Arnaud Scherpereel,Sylvie Lantuejoul,Julien Mazières,Laurent Greillier,Clarisse Audigier-Valette,Emmanuel Bergot,Denis Moro-Sibilot,Olivier Molinier,Hervé Léna,Isabelle Monnet,Franck Morin,Valérie Gounant,Gérard Zalcman

Lung cancer (Amsterdam, Netherlands)（2023）

引用 0|浏览25

暂无评分

摘要

VEGFR2 overexpression independently correlated with longer OS or PFS in PM patients, such biomarker deserving prospective evaluation as stratification variable in future clinical trials.

查看译文

关键词

pleural mesothelioma,cd34 expression,ifct-gfpc

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要